Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
Russell-Mayhew S, McVey G, Bardick A, Ireland A
The Fecal Microbiota Transplantation to Improve Efficacy of Immune Checkpoint Inhibitors in Renal Cell Carcinoma (TACITO, NCT04758507) 52 study is an investigator-initiated, randomized, double-blind, placebo-controlled phase 2a clinical trial designed to determine whether donor FMT from complete ICI responders can enhance the effectiveness of first-line pembrolizumab plus axitinib therapy in patients with mRCC
Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A et al
Partnerships, Expansions and Clinical Milestones Lilly has also aggressively expanded its global reach and partnerships
As expected, Dox treatment elicited ER stress in cells transduced with Ad-TetOn-NHK, but not in cells expressing Ad-GFP
US$ 26.41
US$ 23.58
US$ 27.68
.png)